trientine has been researched along with Bone Loss, Perimenopausal in 2 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G | 2 |
| Men, P | 2 |
| Kenner, GH | 2 |
| Miller, SC | 2 |
2 other studies available for trientine and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation.
Topics: Acetates; Aging; Animals; Bone Density; Chelation Therapy; Female; Humans; Iron; Iron Chelating Agen | 2006 |
Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats.
Topics: Acetates; Animals; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Humans; Iron; Iron C | 2008 |